Ashish Verma MBBS

Assistant Professor, Nephrology

650 Albany St | (617) 638-7339
ashverma@bu.edu

Sections

Nephrology

Biography

Education and Training:
Dr. Ashish Verma earned his medical degree from Government Stanley Medical College in Chennai, India. He completed his internal medicine residency at the University of Tennessee College of Medicine in Chattanooga, followed by a clinical and research fellowship in nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital. During this time, he also held a joint appointment as a Clinical Fellow in Medicine at Harvard Medical School and trained as a research fellow under Dr. Sushrut S. Waikar, focusing on predictors of CKD progression. His work has been supported by an American Heart Association (AHA) Career Development Award.

Academic Leadership & Editorial Roles:
Dr. Verma is a recognized leader in the global nephrology community, contributing to the field's top-tier academic literature. He serves as an Associate Editor for Kidney360 (American Society of Nephrology portfolio). His professional service and recognition include:
American Heart Association: Member of the Kidney in Cardiovascular Medicine Committee.
Framingham Heart Study: Member of the Ancillary Proposals Review Committee.
National Recognition: Named a Top 1% All-Star Nephrology Researcher (2024–2025) by Avant Garde Health.

Research & Scholarship:
As a clinician-investigator at the Boston University Chobanian & Avedisian School of Medicine, Dr. Verma’s research integrates epidemiology, physiology, and proteomics to uncover pathways of Cardiovascular–Kidney–Metabolic (CKM) disease progression. He has authored more than 70 peer-reviewed publications in premier journals, including BMJ, Annals of Internal Medicine, Circulation, JASN, European Heart Journal, and JACC. His 2025 study on long-term risk estimation across CKM stages was selected for the "Best of ASN Journals."

Clinical Expertise & Mentorship:
Clinically, Dr. Verma specializes in chronic kidney disease, acute kidney injury, cardiorenal syndromes, and systemic amyloidosis. As the Lead Nephrologist for the Boston University Amyloidosis Center, he provides multidisciplinary care for patients with complex systemic diseases at Boston Medical Center.
Deeply committed to medical education, Dr. Verma teaches in BU’s Resident Research Course and mentors medical students, residents, and fellows. Under his guidance, his mentees have consistently achieved first-author publications and received national recognition for their research.

Websites

Education

Medicine, MBBS, Stanley Medical School

Publications

Published on 11/25/2025

Claudel SE, Kar D, Majeed A, Burgwinkle PS, Verma A. Assessment and management of albuminuria in adults. BMJ. 2025 Nov 25; 391:e084911. PMID: 41290349.

PubMed

Published on 10/28/2025

Thomas P, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, Schmidt IM, van Raalte DH, Bjornstad P, Layden BT, Lash JP, Waikar SS, Srivastava A. Association of Pancreas Volume With Adverse Clinical Outcomes. J Am Heart Assoc. 2025 Nov 04; 14(21):e042348. PMID: 41147404.

PubMed

Published on 10/21/2025

Zheng Q, Shao J, Teng J, Jin J, Abramov D, Verma A, Xu Y, Zhu Q, Yao J, Lv J, Cai F, Huang P, Zhou H, Zhou J. Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3. JACC Adv. 2025 Oct 21; 102274. PMID: 41165649.

PubMed

Published on 10/10/2025

Schmidt IM, Verma A, Claudel S, Rosan S, Lu W, Beck LH, Huynh C, Palsson R, Srivastava A, Stillman I, Avillach C, Huber TB, Volpe J, Betanzos CM, Ocana MF, Berasi SP, Fader KA, Hassanein M, Waikar SS. Associations of Podocyte-Derived Protein Biomarkers With Foot Process Effacement and Kidney Histopathologic Lesions in Individuals With Glomerular Disease. Kidney Med. 2025 Dec; 7(12):101144. PMID: 41342046.

PubMed

Published on 10/9/2025

Thomas P, Salud M, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, Schmidt IM, van Raalte DH, Bjornstad P, Layden BT, Lash JP, Waikar SS, Srivastava A. Association of pancreas fat fraction with adverse kidney and cardiovascular outcomes. Clin Kidney J. 2025 Dec; 18(12):sfaf310. PMID: 41404372.

PubMed

Published on 8/20/2025

Joshi T, Prokaeva T, Gopal DM, Verma A, Sanchorawala V, Chen H, Burks E, Dasari S, McPhail ED, Staron A. Wild-Type Transthyretin Amyloidosis in the Kidneys. JACC Case Rep. 2025 Sep 24; 30(29):105132. PMID: 40833310.

PubMed

Published on 7/29/2025

Wittig M, Verma A, Bellavia A, Rosan S, Claudel SE, Surapaneni A, Palsson R, Srivastava A, Stillman IE, Henderson JM, Beck LH, Hodgin JB, Grams ME, Rhee EP, Huber TB, Waikar SS, Schmidt IM. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression. Kidney360. 2025 Jul 29. PMID: 40728890.

PubMed

Published on 6/26/2025

Aronov AG, Verma A, Ricardo AC, Kelly TN, Waikar SS, Lash JP, Srivastava A. Associations of Proteinuria Trajectories with Kidney Failure and Death in Individuals with CKD. Kidney360. 2025 Nov 01; 6(11):1890-1898. PMID: 40569689.

PubMed

Published on 5/14/2025

Kar D, Byng R, Sheikh A, Nath M, Zabeen B, Kar S, Banu S, Sarker MHR, Khan N, Acharjee D, Islam S, Allgar V, Ordóñez-Mena JM, El-Wazir A, Song S, Verma A, Kadam U, de Lusignan S. Correction: Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort. BMC Nephrol. 2025 May 14; 26(1):239. PMID: 40369429.

PubMed

Published on 5/2/2025

Claudel SE, Waikar SS, Verma A. Albuminuria References Ranges in Healthy US Adults. J Appl Lab Med. 2025 May 02; 10(3):767-771. PMID: 39981782.

PubMed

View full list of 78 publications.